JP Morgan Maintains Overweight on Anterix, Raises Price Target to $67
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Jerome Darling maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $61 to $67.
JP Morgan analyst Jerome Darling maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $61 to $67.